4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Pharmarise Holdings Corporation (2796) operates in the Pharmaceutical Retailers industry and is headquartered in Tokyo, Japan with about 2,031 employees. Its market capitalization is roughly JPY 6 billion. In the fiscal year ended 2026-05-31, 2796 reported JPY 69.5B in revenue and JPY 114M in net income.
Pharmarise Holdings Corporation manages dispensing pharmacies in Japan. Its dispensing pharmacies provide patients with dispensing services based on prescriptions drawn up by medical institutions. The company also manages drug stores and convenience stores.
Interactive charts & full statements → Open the 2796 valuation workbench →
| Income statement | 2026-05-31 | 2025-05-31 | 2024-05-31 | 2023-05-31 |
|---|---|---|---|---|
| Total Revenue | JPY 69.5B | JPY 63.5B | JPY 54.5B | JPY 52.0B |
| Gross Profit | JPY 9.5B | JPY 9.0B | JPY 8.4B | JPY 8.1B |
| Operating Income (EBIT) | JPY 980M | JPY 294M | JPY 916M | JPY 1.4B |
| Net Income | JPY 114M | (JPY 367M) | (JPY 351M) | JPY 333M |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-05-31 | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|---|---|---|---|---|
| Dividends Paid | (JPY 158M) | (JPY 224M) | (JPY 127M) | (JPY 131M) | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-05-31 | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|---|---|---|---|---|
| Total Assets | JPY 32.7B | JPY 31.9B | JPY 29.5B | JPY 23.4B | — |
| Total Liabilities | JPY 25.8B | JPY 25.0B | JPY 22.0B | JPY 16.4B | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2796 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms